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Brief Report
AGE-RELATED COGNITIVE EFFECTS OF ECT
AND ECT-INDUCED MOOD IMPROVEMENT
IN DEPRESSIVE PATIENTS
P. R. Bosboom, M.Sc., and J. B. Deijen, Ph.D.
This explorative study investigated the interaction between electroconvulsive
therapy (ECT) treatment-effect, reduced depression, and neuropsychological
outcome in relation to age. Follow-up neuropsychological assessment was
conducted with depressive patients treated with ECT. From a potential sample of
45 patients, the neuropsychological measures (pre-ECT, three times post-ECT,
up to 12 months) and clinical data from the remaining 21 patients who
completed all assessments were evaluated (mean age5 56.76; SD5 14.12;
range, 33–79). ECT resulted in a decrease in the depression scores. A distinct
impact of ECT and depression decrease on cognitive domains was found.
Depression alleviation was mainly associated with improvement in cognitive
domains such as memory, information processing, and executive function. ECT
improved cognitive domains such as information processing and perception.
Short-term cognitive improvement was greater in older patients but showed an
increase similar to that at long-term follow-up in younger patients (o60).
Current findings provide evidence that ECT may improve cognitive functioning
in nondemented elderly, which has strong clinical relevance concerning the use
of ECT. Depression and Anxiety 23:93–101, 2006. & 2006 Wiley-Liss, Inc.
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INTRODUCTION
Depression in the older population is a major public
health problem; it has a high prevalence, is frequently
comorbid with medical illnesses, has a negative impact
on quality of life, and carries a high risk of suicide
[Lebowitz et al., 1997; McCall et al., 1999; Serby and
Yu, 2003]. According to fairly recent community-based
studies, minor depression is estimated to occur in more
than 10% of the older population, and major depres-
sion less frequently [Beekman et al., 1999; Forsell and
Winblad, 1999]. Depression in older people is often
therapy resistant, partly because of persistence and
recurrence, and partly because of the interactions with
medicines used to treat their systemic disorders [Fink,
2001]. An extensive literature review, including meta-
analyses, of drug and electroconvulsive therapy (ECT)
treatment of depression in older people between 1996
and 2001, revealed that ECT is more efficacious than
antidepressants, and may therefore be the most
appropriate treatment for severely depressed older
people [Salzman et al., 2002]. As a consequence, in
the last decade, the use of ECT has expanded for the
treatment of older depressive patients.
The American Psychiatric Association Committee on
Electroconvulsive Therapy [2001] considers ECT an
effective treatment for severe depression. The UK
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ECT Review Group [2003] conducted a systematic
review and meta-analyses of randomized controlled
trials and observational studies, concluding that ECT
appears to be an effective short-term treatment for
depression, and that treatment with ECT is more
effective than simulated ECTand pharmacotherapy. In
addition, bilateral ECT is relatively more effective than
unilateral ECT, and high-dose ECT is more effective
than low-dose ECT. However, there is evidence that
one of the adverse effects associated with ECT is
cognitive dysfunction, particularly memory dysfunc-
tion [Rami-Gonzalez et al., 2001]. Contrary to this
evidence, ECT has also been found to have positive
effects on information processing [Hasse-Sander et al.,
1998; Kalb et al., 2003], and so-called ‘‘non-memory
cognition’’ [Calev et al., 1995]. Calev et al. argued that
it is the alleviation of depression, as well as the effects
of ECT itself, that led to the improvement in
cognitive functioning.
With the increase of the older population, particu-
larly the ‘‘older-old’’ age group, it is of growing
importance to clarify and reduce the cognitive risks
associated with ECT in older people. Several studies on
the short-term outcome of ECT in psychiatric patients
indicate that ECT is effective for treating depression in
the older people [Brodaty et al., 2000; Casey and Davis,
1996; Gormley et al., 1998; Kujala et al., 2002; Mulsant
et al., 1991; Rubin et al., 1993; Tew et al., 1999; Tomac
et al., 1997; Williams et al., 1997]. Little is known
about the effects at longer term. Wesson et al. [1997]
were the first to investigate prospectively the longer
term (2–4 years) outcome of ECT-treated, operation-
ally defined depression with respect to age. Their
findings suggested a significant association between
increasing age and probability of improvement prog-
nosis. A more recently published multicenter study
of the Consortium of Research in ECT [CORE;
O’Connor et al., 2001] also reports that age is
positively associated with the response to bilateral
ECT treatment of major depression; remission rates on
the Hamilton Rating Scale for Depression [HRSD;
Hamilton, 1967] for three age-groups—Z65 years,
46–64 years, andr45 years—were 90.0%, 89.8%, and
70.0%, respectively. Age, as a continuous variable,
positively influenced response to treatment [O’Connor
et al., 2001]. Flint and Gagnon reviewed the prior 10
years of research literature in 2002. They concluded
that technical factors, such as electrical stimulation
relative to convulsion threshold, electrode placement
(uni- or bilateral), and frequency of treatment, may
impair cognitive function and should be considered
when balancing efficacy and speed of response with
potential side effects. However, when administered in
an optimal manner, ECT is considered a safe, well-
tolerated, and effective treatment in older patients
[Flint and Gagnon, 2002].
Age is also associated with an increased risk of
cognitive side effects. For example, Zervas et al. [1993]
reported that cognitive deficits, measured 24 to 72 h
after ECT treatment, were more severe in older
individuals. However, these deficits disappeared at
6-month follow-up. In contrast, some other studies
found no indication for differences between older and
younger patients concerning ECT response [Brodaty
et al., 2000; Tew et al., 1999; Wilkinson et al., 1993].
Regarding positive effects on cognition, Wilkinson
et al. found that Mini-Mental State Examination
(MMSE) scores recorded 72 h to 1 week after ECT
course improved in all age groups, but magnitude of
improvement was largest in older patients. In their
review, Flint and Gagnon [2002] commented that this
unexpected finding of improved cognition following
ECT points to a complicated interaction between
cognitive functions, changes in depression, and ECT
administration.
Based on these findings of improved cognitive
performance following ECT [Hanse Sander et al.,
1998; Kalb et al., 2003; Rao and Lyketsos, 2000;
Wesson et al., 1997; Wilkinson et al., 1993], we studied
the distinct effects on neuropsychological outcome of
ECT per se and of reduced depression resulting from
ECT. In addition, we investigated the ECT-induced
cognitive changes in relation to the age of the
patients. We expected ECT to reduce depression
substantially. This alleviated depression was expected
to improve some cognitive functions, that is, those
affecting mainly memory and information processing.
Independently, we expected that ECT would impair
the quality of some cognitive functions and improve
that of others.
MATERIALS AND METHODS
SUBJECTS
Patients were referred to the Psychiatric Hospital
GGZ Delfland in Delft, The Netherlands, for ECT by
their psychiatrists in the region of Delft. All patients in
this study were recruited from this population. They
met the criteria for major depressive episodes of uni- or
bipolar mood disorder according to DSM-IV-R criteria
and were medication resistant, which is a strict
indication for ECT in the Netherlands [Nederlandse
Vereniging voor Psychiatrie, 1992]. They had a
pretreatment score of at least 18 points on the 17-item
HRSD [Hamilton, 1967]. Exclusion criteria for this
study were dementia, premorbid IQ below 70, inade-
quate knowledge of the Dutch language (i.e., non-
native speaker), severe somatic illness, and alcohol or
drug abuse. All patients provided written informed
consent. Initially, a consecutive sample of 45 patients
treated with index ECT between December 1, 1997,
and February 1, 2000, were eligible for this study. All
patients started index ECTas inpatients, and most were
discharged during maintenance treatment and follow-
up measures. Index ECT was defined as the first
treatment course of ECT.
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The neuropsychological assessments took place 1
week before ECT (session 1), 1 to 2 weeks after index
ECT (session 2; M5 6.9 days, SD5 4.75), 6 months
after index ECT (session 3), and 12 months after index
ECT (session 4). From the potential sample of 45
patients, 21 patients (10 males, 11 females; mean
age5 56.76, SD5 14.12; range, 33–79) participated in
all four assessments and were evaluated. The patients
who missed one or two of the following assessments
due to various reasons (e.g., medical events, personal
circumstances, lack of motivation, and protocol viola-
tion) were excluded from this study. Of the 21 patients,
13 met the criteria for major unipolar mood disorder,
and 8 met criteria for major depressive episodes of
bipolar mood disorder. The total group was divided
into older (age 60 or above) or younger patients (n5 9
and n5 12, respectively). Patient characteristics, clin-
ical outcome data, and psychometric measurements of
both groups were compared (Table 1).
ECT DEVICE AND TREATMENT
PROCEDURE
The ECT procedure was conducted according to the
protocols of the Dutch Association of Psychiatry [Van
den Broek et al., 2000], which require that all patients
undergo a complete medical, psychiatric, and labora-
tory examination. Anesthesia was induced with intra-
venous thiopentone sodium (4–5mg/kg) and
succinylcholine (0.5–1.0mg/kg). The blood oxygen
level was kept above 95%. Seizures were induced with
the Thymatron DGx twice weekly, which produced a
customized brief-pulse, constant current, with a max-
imum stimulus level of 1,008 mC. Treatment was
started with right unilateral d’Elia electrode placement,
which was changed to bifrontotemporal bilateral
placement [Kellner et al., 1997] if there was an
insufficient response after six sessions. The stimulus
settings were initially based on age [Abrams, 1997] and
adjusted for the concurrent medication used; the
stimulus setting was adjusted 5–10% upwards with
the use of benzodiazepines and antiepileptics. The
length of the seizures measured by electroencephalo-
gram (EEG) was kept above 20 s. If seizure duration
fell below 20 s, the stimulus setting was raised at the
next session. ECT was stopped when remission was
achieved, if there was a lack of further improvement, or
if intolerable side effects occurred. The mean number
of sessions in an ECT course was 12.17 (SD5 3.93,
range, 5–19). After the ECT course, clinician and
patient decided to continue treatment with either
maintenance pharmacotherapy or maintenance ECT.
Arguments for continuing ECT treatment were
incomplete remission, early signs of relapse, or
preference of the patient for maintenance ECT.
Maintenance ECT has no fixed end point and aims
to prevent recurrence of relapses, like maintenance
pharmacotherapy [American Psychiatric Association,
Committee on Electroconvulsive Therapy, 2001;
Gagne et al., 2000].
In this naturalistic study, antidepressants and mood
stabilizers were used in maintenance pharmacotherapy.
Maintenance ECT was administered the same way
as index ECT, and continued directly after index ECT
for 6 of the 21 patients (5 unilateral, 1 bilateral). One
patient, diagnosed with bipolar I mood disorder
(DMS-IV code: 269.4) switched from maintenance
medication to maintenance ECT after 15 months.
CLINICAL ASSESSMENT
Prior to the ECTcourse a physical examination was
conducted to investigate contraindications to ECT.
The physician who examined the patient also com-
pleted the 17-item HRSD [Hamilton, 1967]. In
addition, for subjective mood evaluation, patients were
asked to complete the Beck Depression Inventory
[BDI; Beck et al., 1961]. These clinical assessments
were not conducted blindly, because patients and
clinicians were aware of treatment conditions. The
mean HRSD score before index ECT for the total
group was 22.52 (SD5 5.93; range, 13–33; med-
ian5 21); two patients had scores lower than 18. The
BDI was not completed by most of the patients during
the first assessment. Therefore, the results on the BDI
could not be analyzed systematically in this study.
During index ECT, weekly clinical assessments using
the same questionnaires were made on the day before
ECT administration. Index ECT was continued until
the HRSD remained stable or complete remission,
defined by a HRSD score below 7.0, was achieved. The
mean HRSD score after ending the ECT course was
8.39 (SD5 6.81; range, 0–30; median5 6.5).
After completing index ECT, clinical assessments
with the HRSD were made by the clinician at irregular
intervals during maintenance ECT or maintenance
pharmacotherapy. Unfortunately, these irregular inter-
vals were not compatible with the neuropsychological
assessments. Therefore, the HRSD could not be used
TABLE 1. Characteristics of the age groups
o60 years Z60 years Total group
Male (N) 7 3 10
Female (N) 5 6 11
Mean age7SD 4676.3 7177.5 57714
Unipolar (N) 7 7 14
Bipolar (N) 5 2 7
HRSD 2275 2377 2376
Maintenance ECT
(N)/medication
4/8 2/7 6/15
Number of index ECT 1373.7 1073.6 1274
Number of unilateral
index ECT
1074 1074 1074
Number of bilateral
index ECT
374 070 274
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as measurement of changes in mood during all four
assessments.
During each neuropsychological assessment, the
patient was asked to complete the BDI and the Dutch
Utrecht’s Coping List [UCL; Scheurs et al., 1993] to
measure the coping style of the patient, that is, the
‘‘depressive reaction pattern.’’ The UCL, a self-rating
scale measuring trait aspects of coping, consists of
seven subscales, one of which is ‘‘depressive reaction
pattern’’ (scores ranging from 7 to 28). The scale is
quite reliable (Cronbach’s a determined in 1,200
healthy employees, alpha5 .70; in 289 patients in a
general practice, a5 .74). The construct validity is
good, as reflected by the observed correlations with the
Zung depression scale (r5 .60) and with trait anxiety of
the State–Trait Anxiety Inventory (r5 .70). Thus, the
‘‘depressive reaction pattern’’ subscale of the UCL is
strongly correlated with anxiety and depression. We
used this scale for measuring changes of depression
because of its correlation with the Zung depression
scale and its high stability [test–retest correlation:
patients in health care center (n5 360; interval 4–
5 months), r5 .69; random sample Dutch population
(n5 229; interval, 17 months), r5 .74].
NEUROPSYCHOLOGICAL ASSESSMENT
Trained neuropsychologists, blind to maintenance
treatment status, performed the neuropsychological
assessments, separately in each patient. Neuropsycho-
logical test sessions took place during the morning and
lasted up to 1.5 h. Participants were tested on attention
and executive functions, memory, and intelligence. The
following tests were administered: (1) the Stroop
Color–Word Test [Hammes, 1978; Stroop, 1935],
measuring attention and inhibition [MacCleod, 1991];
(2) Dutch 10-Word List Memory Test, measuring
long-term verbal learning, parallel versions [Saan and
Deelman, 1986]; (3) the subtests Information, Orienta-
tion, Mental Control, Logical Memory, Digit Span
Forward and Backward, Visual Reproduction, and
Associative Learning from the Wechsler Memory Scale
[WMS; Wechsler, 1974, 1987]; (4) a short version of
the Dutch Groninger Intelligence Test [GIT; Luteijn
and Van der Ploeg, 1982], consisting of the subtests
Verbal Meaning, Word Fluency (categories), Word
Matrices, Visualization, and Closure Speed, resulting
in an intelligence quotient; (5) the experimental
Memory and Orientation Questionnaire [MOQ; Bos-
boom, 2002], measuring the recall of episodic and
semantic memory of general and personal knowledge;
(6) Benton Revised Visual Retention Test [BVRT;
Benton, 1974], measuring visual episodic memory; and
(7) the Subtest Digit Symbol of the Dutch Wechsler
Adult Intelligence Scale [WAIS; Stinissen et al., 1970],
measuring memory consolidation, sustained attention,
visuomotor coordination, and motor response speed
[Lezak, 1995]. Because of sensitivity to practice effects
due to repeated test taking, parallel versions for the
follow-up testing were used to reduce these possible
practice effects [see, e.g., Lezak, 1995].
DATA ANALYSIS
Changes in neuropsychological parameters at two
consecutive test sessions were analyzed both by
analyses of variance (ANOVAs) and covariance (AN-
COVAs) with test session as a repeated measurements
factor. With regard to the ANCOVAs, d depression
(difference between two sessions) was used as covariate.
The comparison of analyses with and without d
depression as covariate made it possible to separate
effects of ECT and depression reduction on cognitive
parameters. If analyses with the covariate d depression,
eliminating the effect of change in depression, yielded a
significant result concerning a specific cognitive para-
meter, ECT was assumed to be responsible for the
obtained effects. In case of a significant ANOVA in
combination with nonsignificant ANCOVA results
concerning the same parameter, effects were assumed
to be caused by alleviated depression; that is, a
significant ANOVA would reflect the effect of d
depression or ECTon neuropsychological parameters.
If this effect disappears after eliminating the influence
of d depression (by using it as a covariate in the
ANCOVA), the significant ANOVA effects can be
attributed to d depression and not to ECT.
In addition, age effects were analyzed by means of
ANOVAs, with age category (below age 60 or age 60
and above) serving as between-subjects factor, and with
sessions 1, 2, 3, and 4 serving as repeated measure-
ments factor.
All statistical analyses were carried out with the
Statistical Package for the Social Sciences (SPSS)
version 10.0 for Windows. Tests were two-tailed, and
a P value of .05 or less was considered significant.
RESULTS
The mean age of the total group of patients was
56.76 (SD5 14.12; range, 33–79; Table 1). There were
no significant differences in patient characteristics and
treatment effects on depression between the age
groups.
Regarding the course of the depression scores of the
UCL, a general decrease in scores was found across
sessions 1, 2, 3, and 4 [F(3, 18)5 8.45, P5.01,
Z25 0.58; mean session 15 19.45, mean session
25 14.9; mean session 35 15.9; mean session
45 16.69]. Specifically, a significant decrease in de-
pression was found only between sessions 1 and 2 [F(1,
20)5 14.3, P5.001, Z25 0.42; mean session 15 19,
mean session 25 15] and between sessions 1 and 4
[F(1, 20)5 10.7, P5.004, Z25 0.35; mean session
45 17]. No reduction in depression was found between
sessions 2 and 3 and between sessions 3 and 4. That
means that cognitive changes between sessions 2 and 3
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and between sessions 3 and 4 can be specifically
attributed to the effects of ECT.
As is pointed out in the Data Analysis section,
cognitive changes during each interval between two
consecutive time points were separately analyzed.
Results of analyses with d depression (i.e., UCL scores)
as covariate reflected the effects of ECT per se on
cognition because of ruling out the effect of changes
in depression. If analyses with d depression did not
yield significant effects but the analyses without
covariate did, the effect was attributed to changes in
depression. Because there was no significant change
in depression between sessions 2, 3, and 4, analyses
with d depression as covariate were only performed
for differences between sessions 1 and 2 and sessions 1
and 4.
Table 2 summarizes the significant results of the
AN(C)OVAs performed on the interval between
sessions 1 and 2, 2 and 3 (6 months after ECT), 3
and 4 (12 months after ECT), and 1 and 4. All
significant effects indicate an improvement in neurop-
sychological functions after ECT, except for Stroop
Card 3, for which an increase in number of errors
was seen.
It is evident in Table 1 that ECT improves all tapped
cognitive domains, which are memory, language,
attention and executive functions, and IQ. Because
the smallest effect size Z2 is 0.20, all effects can be
considered large. In Table 3, we relate these effects to
ECT and/or d depression (i.e., alleviation of depres-
sion). Significant effects with covariate d depression are
attributed to ECT, whereas significant effects without
and nonsignificant effects with covariate are attributed
to reduced depression. As reflected in Table 2, the
alleviation of depression is associated with memory
TABLE 2. Effect size (g2) values of cognitive test variable for the significant differences between test sessions for effect
of mood improvement or ECT (without covariate), and for effect of ECT (with covariate)
Differences between test sessions
1 and 2b 2 and 3 3 and 4 1 and 4
Without covariate With covariate Without covariate Without covariate Without covariate With covariate
Cognitive test variablea Z2 P Z2 P Z2 P Z2 P Z2 P Z2 P
&WMS Paired Associates 0.23 0.029 0.23 0.037 0.47 0.019 0.48 0.027
& 10-word List 0.23 0.029 0.31 0.021
&BVRT Correct Responses 0.20 0.048 0.27 0.031
&WMS Visual Reproduction 0.39 0.039 0.45 0.034
&WMS Orientation 0.27 0.017 0.28 0.019 0.25 0.041
&MOQ Semantic Recent 0.50 0.033
&GIT Word Matrices 0.53 0.017
&Stroop Card II speed 0.38 0.007 0.48 0.026 0.48 0.039
&Stroop Card III speed 0.40 0.048
&Stroop Card III faults 0.24 0.037 0.26 0.043
&WAIS Digit Symbol 0.28 0.017 0.28 0.024 0.43 0.028 0.47 0.029
&WMS Mental Control 0.22 0.043
&GIT IQ 0.65 0.005
&GIT Incomplete Pictures 0.42 0.03 0.56 0.013
&GIT Visualization 0.65 0.005 0.39 0.05
aSee text for description of tests.
bSession 1, one week before ECT index; session 2, one week after ECT index; session 3, 6 months after session 3; 6 months after session 3.
TABLE 3. Summary of positive effects on neuropsycho-
logical test scores dominated by effect of elevation of
depression (DEP) or ECT at short and long term
Differences between test sessions
Cognitive test variablea 1 and 2 2 and 3 3 and 4 1 and 4
WMS Paired Associates ECT ECT
10-Word List DEP ECT
BVRT Correct Responses ECT
WMS Visual Reproduction ECT
WMS Orientation ECT ECT
MOQ Semantic Recent ECT
GIT Word Matrices ECT
Stroop Card II speed DEP ECT
Stroop Card III speed DEP
WAIS Digit Symbol ECT ECT
WMS Mental Control ECT
GIT IQ ECT
GIT Incomplete Pictures ECT
GIT Visualization ECT ECT
aSee text for description of tests.
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improvement (verbal learning on a 10-word list),
increased speed of information processing (Stroop
Card II) and inhibition (Stroop Card III). ECT per
se affects mainly memory improvement and speed of
information processes as well, plus visual organization
and mental control.
We studied age effects by evaluating possible
interaction effects between the test sessions and the
factor age (less than age 60, and age 60 and above).
Mean age, severity of depression, and ECT parameters
of each age group are shown in Table 1. A significant
interaction between age and sessions 1 and 2 was found
for the WMS Memory Quotient (MQ), WMS Mental
Control score and WMS Visual Reproduction [F(1,
19)5 4.6, P5.04; F(1, 19)5 5.4, P5.03; and F(1,
19)5 4.5, P5.05, respectively; see Figs. 1, 2, and 3).
The improvement on these tasks between sessions 1
and 2 is greater in the older group than in the younger
group. However, as is clear from Figures 1–3, between
sessions 2 and 3, the older group shows a decrease
followed by an increase in performance between
sessions 3 and 4.
DISCUSSION
We investigated the cognitive effects of ECT
treatment and interpreted the results in terms of
the differential effect of reduced depression and the
effects of ECT in relation to age. Our hypothesis
that both ECT and reduced depression specifically
affect cognitive function was confirmed. The analyses
we used (i.e., with and without the effect of differences
in depression between pre-ECT measures and three
post-ECT measures) made it possible to separate the
effects of ECT treatment and reduced depression.
Indeed, the results demonstrate a distinctive impact
of ECT treatment per se and reduced depression
on different cognitive domains. First, the ECT
90
95
100
105
110
115
120
125
1
test session
w
m
s 
m
em
o
ry
 q
uo
tie
nt
432
< 60 yrs 
60 yrs and older
Figure 1. Mean scores [7 SEM (standard error of mean)] on the Wechsler Memory Quotient (MQ) for the young and older patient
groups at the four test sessions.
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Figure 2. Mean scores (7 SEM) on the subtest Wechsler Concentration for the young and older patient groups at the four test sessions.
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treatment improves nearly all tapped cognitive domains
[i.e., executive functions and attention, (anterograde
and retrograde) verbal and nonverbal memory, and
intelligence]. ECT per se affects not only memory at
short term (within 2 weeks after index ECT) and at
long term (up to 1 year), and speed of information
processes (at long-term), but also the quality of visual
organization and mental control (at long term).
Reduced depression improves memory (i.e., perfor-
mances on verbal learning, at short term), speed of
information processing (at short term), and inhibition
(at long term). Second, this study demonstrated
differences between adult and older patients at
short and long term regarding changes in cognitive
performance after index ECT. Remarkably, cognitive
improvement shortly after index ECT is more pro-
nounced in patients over 60 years of age, but shows a
similar increase in performance at long term. However,
as the number of the older patients is quite small
(n5 9) and subjects over age 80 were not included in
our sample, we have to be careful in generalizing these
finding to all patients.
To our knowledge, this is the first time that
treatment with index ECT of a geriatric patient
group with medication-resistant depression shows
cognitive improvement that lasts for at least 1 year
[Flint and Gagnon, 2002; Tew et al., 1999; Wesson
et al., 1997; Wilkinson et al., 1993; Zervas et al., 1993].
The results, although based on a relatively small
number of subjects, thus indicate that older people
given ECT for severe mood disorder do not suffer
cognitive decline at long-term follow-up, but even
show a benefit of ECT treatment. The current
findings provide evidence that for nondemented
(as being one of the criteria of this study) older
people, ECT may be accompanied by improved
cognitive functioning that lasts for at least 1 year. This
outcome provides another view on the use of ECT in
older people.
The improvement in cognitive functions might be
explained by g-aminobutyric acid (GABA) involvement
in ECT’s mechanism [Sanacora et al., 2003], and/or by
neurochemical and neuromodulation cascade effects
initiated by repeated treatments [Wahlund and Von
Rosen, 2003]. Indeed, increased cortical GABA con-
centrations have been found in depressed patients
receiving ECT [Sanacora et al., 2003]. In addition,
single and repeated ECT activates dopaminergic and
serotonergic neurotransmission in the frontal cortex of
rats [Yoshida et al., 1998]. There is also evidence that
ECT may have a noradrenergic mechanism of action
[Deakin et al., 1981]. The cognitive effects may be
differentially related for GABA, noradrenaline (NA),
serotonin (5-HT), and dopamine (DA).
In humans, higher levels of DA have been related to
better working memory [Deijen, 1993], and central NA
has been found to be important in maintaining
attention [Smith and Nutt, 1996]. Treatment of
rodents with 5-HT or GABA receptor antagonists
generally produces a memory-enhancing effect,
whereas GABA-ergic agonists impair retention [Deijen,
1993]. Thus, the general picture is that higher levels of
DA and NA are positively associated with learning and
memory, whereas higher levels of 5-HTor GABA seem
to impair cognitive processes. It may well be true that
the positive cognitive effects we obtained are related to
increased activity of catecholaminergic neurons, which
then dominate the adverse cognitive effects associated
with increased levels of 5-HT and GABA. Opposed to
the view of neurochemical involvement in the cognitive
improvement, major or bipolar depression presents a
severe illness leading to long-standing cognitive
impairment from which the brain takes a substantial
time to recover. Thus, even though mood is improved,
the long-standing effects on cognition may take
significantly more time to clear.
The differential observations of cognitive side effects
of ECT may be related to the degree of cognitive
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Figure 3. Mean scores (7 SEM) on the subtest Wechsler Visual Reproduction for the young and older patient groups at the four
test sessions.
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reserve (CR), which implies that innate intelligence or
aspects of life experience such as educational or
occupational attainments may supply a reserve against
brain dysfunction in the face of acquired central
nervous system (CNS) dysfunction. It has been
observed that following three ECT treatments, a
high-CR group forgot significantly less information
after a 30-min delay compared to a low-CR group
[Legendre et al., 2003]. Possibly a higher than average
CR in our subjects may explain the observed ECT-
induced cognitive improvement in this study.
Studies so far have been controversial regarding the
association between age and the severity and persis-
tence of ECT-related cognitive effects [Tew et al.,
1999; Wilkinson et al., 1993; Zervas et al., 1993]. Our
results confirm the results of Wilkinson et al. [1993],
who found the largest improvement in MMSE scores
in older patients. Wesson et al. [1997] showed a
significant association between increasing age and
better prognosis, but unfortunately they did not
include cognitive measurements in their follow-up
study. The more recent study of Brodaty et al. [2000]
did include cognitive measures but did not provide
details of ECT-techniques used. In a review, Flint and
Gagnon [2002] concluded that ECTcan be used safely
in patients of very advanced age, with appropriate
evaluation and monitoring, and administration in an
optimal way. They suggest that the superior response
to ECT among older compared with younger adults
might not be related to aging per se but to age-related
clinical factors, such as lengthier depressive episodes
and more melancholic features in their mood. How-
ever, the finding that the same ECT procedure may
have a more beneficial cognitive effect in the older
brain may be explained by the possibility that stimula-
tion of the neural system is instrumental in the process
of restorative plasticity in especially senescent brains
[Swaab, 1991]. During aging, not only degenerative
processes take place but also adaptive growth responses
and regenerative processes in which stimulation of
neuronal systems might be beneficial. Neuronal
activation might prolong optimal neural function,
which may explain the superior acute effect of ECT
in older people. However, our results indicate that
6 months after ECT treatment, the cognitive outcome
in the older subjects declines to the level of the younger
age group; that is, the superior beneficial cognitive
effect in older patients seems to be temporary. It may
well be true that the acute ECT treatment effect in the
older age group reflects a ceiling effect whose response
is normalized in the follow-up period. After the
fallback at 6 months, the increase in cognition in
the older age group is continued at the average,
normal rate.
Limitations of this explorative study need to be
acknowledged. For example, the patients in this study,
who were regularly followed up over 1 year, were
highly compliant and thus may represent a quite select
sample of patients (i.e., selection-bias possibility).
Although the data are suggestive, the sample size in
this study was small; larger study group sizes will be
required to confirm the present beneficial age-related
effects of ECT and the distinctive impact of ECT and
reduced depression on neuropsychological outcome.
Still, current findings provide evidence that ECT may
be accompanied by improved cognitive functioning
in both adult and older depressive patients, which
has strong clinical relevance concerning the use of
index ECT.
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